SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling
Min Sun(Qilu Hospital of Shandong University), Xuetian Yue(Shandong University)
Cited by 22
Related Papers
Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression
|Genes & Development|2017|48
<scp>SREBF2–STARD4</scp> axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis
|Cancer Science|2022|36
ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
|Cancer Cell International|2022|21
P4HA2 promotes the progression of papillary thyroid cancer by enhancing degradation of IκBα to activate NF-κB signaling pathway
|Cancer Cell International|2025|1
SHMT2 promotes thyroid cancer metastasis through epigenetic activation of AKT signaling
|Research Square|2023|0